Form D Explorer

Form D — Oncotelic Therapeutics, Inc.

0001493152-26-034225 · filed Jul 22, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
06b
Reported offering amount
$711,840
Reported amount sold
$711,840
Minimum investment
$0
Investors
33
Sales commission
$0
Finders' fees
$0

Issuer

Name
Oncotelic Therapeutics, Inc.
CIK
908259
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
29397 AGOURA ROAD
AGOURA HILLS, CA 91301
Phone
650-635-7000

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗